방사선종양학

본문글자크기
  • [Clin Cancer Res.] Oligosaccharyltransferase 억제가 Receptor Tyrosine Kinase 활성화를 억제하고 교모종의 방사선감수성을 증가시킴

    Oligosaccharyltransferase Inhibition Reduces Receptor Tyrosine Kinase Activation and Enhances Glioma Radiosensitivity.

    Yale University Medical School / Joseph Contessa*

  • 출처
    Clin Cancer Res.
  • 등재일
    2019 Jan 15
  • 저널이슈번호
    25(2):784-795. doi: 10.1158/1078-0432.CCR-18-0792. Epub 2018 Jul 2.
  • 내용

    바로가기  >

    Abstract
    PURPOSE:
    Parallel signaling reduces the effects of receptor tyrosine kinase (RTK)-targeted therapies in glioma. We hypothesized that inhibition of protein N-linked glycosylation, an endoplasmic reticulum co- and posttranslational modification crucial for RTK maturation and activation, could provide a new therapeutic approach for glioma radiosensitization.Experimental Design: We investigated the effects of a small-molecule inhibitor of the oligosaccharyltransferase (NGI-1) on EGFR family receptors, MET, PDGFR, and FGFR1. The influence of glycosylation state on tumor cell radiosensitivity, chemotherapy-induced cell toxicity, DNA damage, and cell-cycle arrest were determined and correlated with glioma cell receptor expression profiles. The effects of NGI-1 on xenograft tumor growth were tested using a nanoparticle formulation validated by in vivo molecular imaging. A mechanistic role for RTK signaling was evaluated through the expression of a glycosylation-independent CD8-EGFR chimera.

    RESULTS:
    NGI-1 reduced glycosylation, protein levels, and activation of most RTKs. NGI-1 also enhanced the radiosensitivity and cytotoxic effects of chemotherapy in those glioma cells with elevated ErbB family activation, but not in cells without high levels of RTK activation. NGI-1 radiosensitization was associated with increases in both DNA damage and G1 cell-cycle arrest. Combined treatment of glioma xenografts with fractionated radiotherapy and NGI-1 significantly reduced tumor growth compared with controls. Expression of the CD8-EGFR eliminated the effects of NGI-1 on G1 arrest, DNA damage, and cellular radiosensitivity, identifying RTK inhibition as the principal mechanism for the NGI-1 effect.

    CONCLUSIONS:
    This study suggests that oligosaccharyltransferase inhibition with NGI-1 is a novel approach to radiosensitize malignant gliomas with enhanced RTK signaling.See related commentary by Wahl and Lawrence, p. 455.

     


    Author information

    Baro M1, Lopez Sambrooks C1, Quijano A2, Saltzman WM2, Contessa J3,4.
    1
    Department of Therapeutic Radiology, Yale University, New Haven, Connecticut.
    2
    Department of Biomedical Engineering, Yale University, New Haven, Connecticut.
    3
    Department of Therapeutic Radiology, Yale University, New Haven, Connecticut. joseph.contessa@yale.edu.
    4
    Department of Pharmacology, Yale University, New Haven, Connecticut.

  • 덧글달기
    덧글달기
       IP : 18.232.127.73

    등록